Financial Performance - The company reported a total revenue of 229 million yuan for the first half of 2025, representing a year-on-year increase of 6.95% [1] - The net profit attributable to the parent company reached 16.71 million yuan, up 7.74% year-on-year [1] - In Q2 2025, total revenue was 124 million yuan, with a year-on-year growth of 2.32% [1] - The gross margin improved to 54.55%, an increase of 3.4% year-on-year, while the net margin rose to 7.31%, up 0.74% year-on-year [1] Key Financial Ratios - The company’s total expenses (selling, administrative, and financial) amounted to 67.02 million yuan, accounting for 29.3% of revenue, which is an increase of 8.03% year-on-year [1] - The cash flow per share increased significantly by 66.67% to 0.06 yuan [1] - The company’s return on invested capital (ROIC) was reported at 2.11%, indicating a relatively weak capital return [3] Market and Business Insights - The company’s performance is primarily driven by research and development, focusing on new technologies and market demands [3] - The company has seen a significant increase in cash assets, with cash holdings rising to 238 million yuan, a 23.29% increase year-on-year [1] - The company is actively exploring new markets and customer opportunities, particularly in emerging fields such as healthcare and automotive [4] Fund Holdings - The largest fund holding the company’s shares is the Southern Zhihong Mixed A fund, which increased its holdings to 387,600 shares [4] - The fund has shown a strong performance, with a 42.19% increase over the past year [4]